ConductScience.org, home

Paper28292939

A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Chien MH and 8 others. Mol Cancer Ther, 2017. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio. Papers, record 28292939. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28292939

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
PubMed
Journal
Mol Cancer Ther
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2020-09-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chien MHMing-Hsien
2Chang WMWei-Min
3Lee WJWei-Jiunn
4Chang YCYu-Chan
5Lai TCTsung-Ching
6Chan DVDerek V
7Sharma RRahul
8Lin YFYuan-Feng
9Hsiao MMichael

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Monoclonal, HumanizedMajor topic
Antibody-Dependent Cell CytotoxicityMajor topic
Carcinoma, Squamous CellMajor topic
Fas Ligand ProteinMajor topic
GlycoproteinsMajor topic
Mouth NeoplasmsMajor topic
Recombinant Fusion ProteinsMajor topic
fas ReceptorMajor topic
Animals
Antigens, Neoplasm
Cell Line, Tumor
Cell Survival
Cell Transformation, Neoplastic
Disease Models, Animal
Humans
Mice
Prognosis
Protein Binding
Single-Chain Antibodies
Tumor Burden
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI116725NIAID NIH HHSUnited StatesR01AI116725PubMed and NIHNIH RePORTER
R01 DK105833NIDDK NIH HHSUnited StatesR01DK105833PubMed and NIHNIH RePORTER

Download CSV of grants

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117406307Subcellular imaging in the live mouse.Nat Protoc2006https://conductscience.org/library/papers/17406307PubMed
217482535The CD95 receptor: apoptosis revisited.Cell2007https://conductscience.org/library/papers/17482535PubMed
319411038Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer.Oral Oncol2009https://conductscience.org/library/papers/19411038PubMed
412654254NF-kappaB in cancer: a marked target.Semin Cancer Biol2003https://conductscience.org/library/papers/12654254PubMed
517406431Whole-body imaging with fluorescent proteins.Nat Protoc2006https://conductscience.org/library/papers/17406431PubMed
622508480Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.Oncogene2013https://conductscience.org/library/papers/22508480PubMed
710537320Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.Cancer Res1999https://conductscience.org/library/papers/10537320PubMed
812657360Apoptotic signaling cascades.Prog Neuropsychopharmacol Biol Psychiatry2003https://conductscience.org/library/papers/12657360PubMed
919266094The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.PLoS One2009https://conductscience.org/library/papers/19266094PubMed
1011375993Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).J Biol Chem2001https://conductscience.org/library/papers/11375993PubMed
1111212252Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.Cancer Res2001https://conductscience.org/library/papers/11212252PubMed
1215486063Induction of tolerance using Fas ligand: a double-edged immunomodulator.Blood2005https://conductscience.org/library/papers/15486063PubMed
1322902507Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents.Cancer Lett2013https://conductscience.org/library/papers/22902507PubMed
1422434316Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.Pathol Oncol Res2012https://conductscience.org/library/papers/22434316PubMed
1510702789Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49.Oral Dis2000https://conductscience.org/library/papers/10702789PubMed
1623497165A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer.J Biomed Sci2013https://conductscience.org/library/papers/23497165PubMed
1726422835Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts.Nat Rev Cancer2015https://conductscience.org/library/papers/26422835PubMed
1819794494Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.Nature2009https://conductscience.org/library/papers/19794494PubMed
199547332Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.J Exp Med1998https://conductscience.org/library/papers/9547332PubMed
2025656654The role of CD95 and CD95 ligand in cancer.Cell Death Differ2015https://conductscience.org/library/papers/25656654PubMed

See all 50 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
40593750Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy.Nat Commun2025https://conductscience.org/library/papers/40593750PubMed
40445465The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy.Funct Integr Genomics2025https://conductscience.org/library/papers/40445465PubMed
38534392Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration.Cells2024https://conductscience.org/library/papers/38534392PubMed
38068849Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death.Nutrients2023https://conductscience.org/library/papers/38068849PubMed
35682983Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment.Int J Mol Sci2022https://conductscience.org/library/papers/35682983PubMed
35249111FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis.Cell Death Discov2022https://conductscience.org/library/papers/35249111PubMed
33671651sFasL-The Key to a Riddle: Immune Responses in Aging Lung and Disease.Int J Mol Sci2021https://conductscience.org/library/papers/33671651PubMed
31555392Evaluation of IC50 levels immediately after treatment with anticancer reagents using a real-time cell monitoring device.Exp Ther Med2019https://conductscience.org/library/papers/31555392PubMed
31455874Inferring novel genes related to oral cancer with a network embedding method and one-class learning algorithms.Gene Ther2019https://conductscience.org/library/papers/31455874PubMed
30308958Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review.Cancers (Basel)2018https://conductscience.org/library/papers/30308958PubMed
28673349Site-specific chemical conjugation of human Fas ligand extracellular domain using trans-cyclooctene - methyltetrazine reactions.BMC Biotechnol2017https://conductscience.org/library/papers/28673349PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28292939

GET https://conductscience.org/api/papers/v1/28292939/references?page=2